Stella Fortis

Stella Fortis is a healthcare project development company focused on building strategic partnerships and innovative initiatives across the pharmaceutical, biotechnology, genetic diagnostics, and medical device sectors.

Medical Devices Market Development

Supporting the introduction and growth of innovative medical technologies

Stella Fortis supports medical device companies in entering and expanding within the Southeast European market, with a strong focus on Serbia. We work with international manufacturers to ensure that innovative technologies are effectively positioned and aligned with local healthcare systems and market needs.

Our work combines strategic guidance with practical execution, enabling a structured and efficient market entry process and supporting long-term market development.

What we do

Market Entry & Positioning Strategy
Development of tailored strategies based on local market structure, competition and healthcare dynamics
Regulatory & Market Access Support
Guidance through local registration processes in collaboration with trusted regulatory partners
Distribution Strategy & Partner Selection
Identification and onboarding of appropriate local distributors, aligned with product and market specifics
Market Development & Implementation
Supporting the introduction of medical devices through structured rollout plans and coordination with key stakeholders
Strategic Project Management
End-to-end support from initial market assessment to implementation and expansion

Our approach

We focus on creating realistic and executable strategies that reflect the specifics of the local healthcare environment. By combining market insight with hands-on coordination, we ensure that medical devices are not only introduced, but positioned for sustainable growth.

Project Example: Women’s Health Medical Devices

Stella Fortis is actively involved in the market development of innovative medical devices in gynecology and urogynecology, supporting the introduction of modern therapeutic solutions for pelvic floor disorders and broader women’s health conditions.

In collaboration with For.Me.Sa. Srl (Italy), Stella Fortis has supported the introduction of advanced pessary solutions into the Serbian market, contributing to the availability of non-surgical treatment options for pelvic organ prolapse and related conditions — an important step in improving patient care and expanding therapeutic choices.

The project includes:

Market analysis and strategic positioning
Regulatory support and market access
Identification and onboarding of distribution partners
Collaboration with leading medical institutions
Organization of professional education and clinical introduction of new solutions

Through this initiative, we aim to contribute to improving standards of women’s healthcare and expanding access to effective, minimally invasive treatment options across the region.

Genetic Medicine & Precision Diagnostics

Stella Fortis develops strategic initiatives in the field of genetic diagnostics and precision medicine, with a particular focus on reproductive genetics, oncology diagnostics, and rare diseases.

Genetic Medicine

– Reproductive Genetics (PGT)
– Oncogenetics
– Carrier Screening & Rare Diseases
– Scientific Collaboration
– Partner Laboratories&Clinics

Scientific & Professional Initiatives

GenLife – Association for Genetic Diagnostics & Personalized Medicine
Educational programs
Conferences, Workshops and training programs